At-Risk Patients
Iron deficiency (ID) and iron deficiency anemia (IDA) often happen alongside other biological or health conditions. If untreated, low iron levels can lead to worsening symptoms.
The ACCRUFeR® (ferric maltol) impact
These profiles represent the types of people with an increased risk for ID and IDA.
People with Inflammatory Conditions
Inflammation makes it harder for the body to use and absorb iron. At the same time, ID can worsen inflammation.
ACCRUFeR's unique design is proven to make absorption and tolerability possible for people with ID/IDA and inflammatory conditions.
Women
Women are more likely than men to experience ID and IDA and almost one third of women experience IDA over the course of their lives.
ACCRUFeR is clinically proven to deliver rapid and effective results for adults with ID/IDA.
Children Aged 10 and Older
Untreated ID and IDA in children can cause lasting developmental issues.
ACCRUFeR is the only FDA-approved branded oral iron treatment for children 10 years of age and older.